Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 29, 2023

Rubicon Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for RUBICON, and what generic and branded alternatives to RUBICON drugs are available?

RUBICON has forty-six approved drugs.

There is one tentative approval on RUBICON drugs.

Summary for Rubicon

US Patents:	0
Tradenames:	41
Ingredients:	41
NDAs:	46

Drugs and US Patents for Rubicon

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Rubicon	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	090807-001	May 2, 2012	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Rubicon	PRIMIDONE	primidone	TABLET;ORAL	214896-002	Jun 28, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Rubicon	BISOPROLOL FUMARATE	bisoprolol fumarate	TABLET;ORAL	075643-002	Nov 16, 2000	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Rubicon	LEVOFLOXACIN	levofloxacin	SOLUTION/DROPS;OPHTHALMIC	078282-001	Dec 20, 2010		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Rubicon	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; triamterene	TABLET;ORAL	216211-001	Feb 23, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Rubicon	ISOSORBIDE DINITRATE	isosorbide dinitrate	TABLET;ORAL	215723-002	Jul 8, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Rubicon

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

Johnson and Johnson

Colorcon

Baxter

McKinsey

McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.